Multi-modal cancer therapy using viral hitchhiking
Cancer therapies based on immunological methods are a rapidly expanding field of cancer treatment options. However, one major problem immunebased cancer therapies face is that cancer cells manage to escape immunological control during their evolution. Methods enabling the immune system to rerecognize tumor cells are therefore an essential part of immune cancer therapies. The present invention is based on a fusion protein that substantially enhances the tumordestroying effect of T-cells against tumor cells marked with Newcastle disease virus (NDV).
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Nerve cells of blind mice retain their visual function
Nerve cells in the retina were analysed at TU Wien (Vienna) using microelectrodes. They show astonishingly stable behavior – good news for retina implants. The retina is often referred to…
State-wide center for quantum science
Karlsruhe Institute of Technology joins IQST as a new partner. The mission of IQST is to further our understanding of nature and develop innovative technologies based on quantum science by…
Newly designed nanomaterial
…shows promise as antimicrobial agent. Rice scientists develop nanocrystals that kill bacteria under visible light. Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective…